164 related articles for article (PubMed ID: 38148058)
21. Novel microminipig model of atherosclerosis by high fat and high cholesterol diet, established in Japan.
Miyoshi N; Horiuchi M; Inokuchi Y; Miyamoto Y; Miura N; Tokunaga S; Fujiki M; Izumi Y; Miyajima H; Nagata R; Misumi K; Takeuchi T; Tanimoto A; Yasuda N; Yoshida H; Kawaguchi H
In Vivo; 2010; 24(5):671-80. PubMed ID: 20952732
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory effect of co-administration of atorvastatin and endothelin-1 receptor antagonist on the progression of atherosclerosis in rabbit.
Sun Y; Liu J; Yang B; Sai X; Li T; Wang D; Zhou R
APMIS; 2014 Jun; 122(6):556-64. PubMed ID: 24164644
[TBL] [Abstract][Full Text] [Related]
23. All-trans retinoic acid effectively reduces atheroma plaque size in a rabbit model of high-fat-induced atherosclerosis.
Zarei L; Bahrami M; Farhad N; Froushani SMA; Abbasi A
Adv Clin Exp Med; 2018 Dec; 27(12):1631-1636. PubMed ID: 30048051
[TBL] [Abstract][Full Text] [Related]
24. Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve.
Rajamannan NM; Subramaniam M; Springett M; Sebo TC; Niekrasz M; McConnell JP; Singh RJ; Stone NJ; Bonow RO; Spelsberg TC
Circulation; 2002 Jun; 105(22):2660-5. PubMed ID: 12045173
[TBL] [Abstract][Full Text] [Related]
25. Long noncoding RNA lncARSR promotes hepatic cholesterol biosynthesis via modulating Akt/SREBP-2/HMGCR pathway.
Huang J; Chen S; Cai D; Bian D; Wang F
Life Sci; 2018 Jun; 203():48-53. PubMed ID: 29678744
[TBL] [Abstract][Full Text] [Related]
26. Rho kinase inhibitor fasudil mitigates high-cholesterol diet-induced hypercholesterolemia and vascular damage.
Abdali NT; Yaseen AH; Said E; Ibrahim TM
Naunyn Schmiedebergs Arch Pharmacol; 2017 Apr; 390(4):409-422. PubMed ID: 28101628
[TBL] [Abstract][Full Text] [Related]
27. Diet induced mild hypercholesterolemia in pigs: local and systemic inflammation, effects on vascular injury - rescue by high-dose statin treatment.
Busnelli M; Manzini S; Froio A; Vargiolu A; Cerrito MG; Smolenski RT; Giunti M; Cinti A; Zannoni A; Leone BE; Forni M; Bacci ML; Biasi GM; Giovannoni R; Lavitrano M
PLoS One; 2013; 8(11):e80588. PubMed ID: 24260430
[TBL] [Abstract][Full Text] [Related]
28. Effect of atorvastatin on atherosclerotic plaque formation and platelet activation in hypercholesterolemic rats.
Gocmen AY; Ocak GA; Ozbilim G; Delibas N; Gumuslu S
Can J Physiol Pharmacol; 2013 Sep; 91(9):680-5. PubMed ID: 23984971
[TBL] [Abstract][Full Text] [Related]
29. The Ossabaw Pig Is a Suitable Translational Model to Evaluate Dietary Patterns and Coronary Artery Disease Risk.
Matthan NR; Solano-Aguilar G; Meng H; Lamon-Fava S; Goldbaum A; Walker ME; Jang S; Lakshman S; Molokin A; Xie Y; Beshah E; Stanley J; Urban JF; Lichtenstein AH
J Nutr; 2018 Apr; 148(4):542-551. PubMed ID: 29659954
[TBL] [Abstract][Full Text] [Related]
30. Protective effect of atorvastatin meditated by HMGCR gene on diabetic rats with atherosclerosis: An in vivo and in vitro study.
Wang YZ; Yang L; Li CF
Biomed Pharmacother; 2018 Aug; 104():240-251. PubMed ID: 29775891
[TBL] [Abstract][Full Text] [Related]
31. Fluvastatin prevents renal injury and expression of lactin-like oxidized low-density lipoprotein receptor-1 in rabbits with hypercholesterolemia.
Yu YH; Wang Y; Dong B; Sun SZ; Chen Y; Meng XH; Liu ZZ
Chin Med J (Engl); 2005 Apr; 118(8):621-6. PubMed ID: 15899115
[TBL] [Abstract][Full Text] [Related]
32. Rapid development of atherosclerosis in the world's smallest Microminipig fed a high-fat/high-cholesterol diet.
Kawaguchi H; Yamada T; Miura N; Ayaori M; Uto-Kondo H; Ikegawa M; Noguchi M; Wang KY; Izumi H; Tanimoto A
J Atheroscler Thromb; 2014; 21(3):186-203. PubMed ID: 24257467
[TBL] [Abstract][Full Text] [Related]
33. High-Risk Polymorphisms Associated with the Molecular Function of Human HMGCR Gene Infer the Inhibition of Cholesterol Biosynthesis.
Das KC; Hossain MU; Moniruzzaman M; Salimullah M; Akhteruzzaman S
Biomed Res Int; 2022; 2022():4558867. PubMed ID: 35707384
[TBL] [Abstract][Full Text] [Related]
34. Atorvastatin inhibits the 5-lipoxygenase pathway and expression of CCL3 to alleviate atherosclerotic lesions in atherosclerotic ApoE knockout mice.
Yang LX; Heng XH; Guo RW; Si YK; Qi F; Zhou XB
J Cardiovasc Pharmacol; 2013 Aug; 62(2):205-11. PubMed ID: 23615158
[TBL] [Abstract][Full Text] [Related]
35. Resveratrol protects against atherosclerosis, but does not add to the antiatherogenic effect of atorvastatin, in APOE*3-Leiden.CETP mice.
Berbée JF; Wong MC; Wang Y; van der Hoorn JW; Khedoe PP; van Klinken JB; Mol IM; Hiemstra PS; Tsikas D; Romijn JA; Havekes LM; Princen HM; Rensen PC
J Nutr Biochem; 2013 Aug; 24(8):1423-30. PubMed ID: 23337345
[TBL] [Abstract][Full Text] [Related]
36. Simulation of Lipid-Lowering Therapy Intensification in a Population With Atherosclerotic Cardiovascular Disease.
Cannon CP; Khan I; Klimchak AC; Reynolds MR; Sanchez RJ; Sasiela WJ
JAMA Cardiol; 2017 Sep; 2(9):959-966. PubMed ID: 28768335
[TBL] [Abstract][Full Text] [Related]
37. Hypercholesterolemia treatment patterns and low-density lipoprotein cholesterol monitoring in patients with a diagnosis of atherosclerosis in clinical practice.
Davidson MH; Gandhi SK; Ohsfeldt RL; Fox KM
Am J Med; 2009 Jan; 122(1 Suppl):S51-9. PubMed ID: 19110088
[TBL] [Abstract][Full Text] [Related]
38. A Mendelian Randomization Approach Using 3-HMG-Coenzyme-A Reductase Gene Variation to Evaluate the Association of Statin-Induced Low-Density Lipoprotein Cholesterol Lowering With Noncardiovascular Disease Phenotypes.
Liu G; Shi M; Mosley JD; Weng C; Zhang Y; Lee MTM; Jarvik GP; Hakonarson H; Namjou-Khales B; Sleiman P; Luo Y; Mentch F; Denny JC; Linton MF; Wei WQ; Stein CM; Feng Q
JAMA Netw Open; 2021 Jun; 4(6):e2112820. PubMed ID: 34097045
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the effects of escitalopram and atorvastatin on diet-induced atherosclerosis in rats.
Unis A; Abdelbary A; Hamza M
Can J Physiol Pharmacol; 2014 Mar; 92(3):226-33. PubMed ID: 24593787
[TBL] [Abstract][Full Text] [Related]
40. Perspectives of the non-statin hypolipidemic agents.
Rozman D; Monostory K
Pharmacol Ther; 2010 Jul; 127(1):19-40. PubMed ID: 20420853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
